Mediso works in the field of design and manufacturing of high-end clinical and life science research multi-modality in vivo molecular imaging systems.
All preclinical imagers are highly integrated and include MultiCell small-animal environment systems to provide anesthesia support and temperature monitoring functions to lab animals during the preparation stage and the imaging process enabling 4D-, 5D imaging applications including cardiac and pulmonary gating.
nanoScan Products comes complete with inherently multi-modal powerful, easy to use software solutions for each phase of your preclinical workflow:
Boston, MA, September 28, 2015 /PRNewswire/ Mediso USA is proud to announce the tenth site of integrated preclinical multimodality imagers of the nanoScan Family in North America, at the preeminent Cold Spring Harbor Laboratory (CSHL).
Salt Lake City, Utah and Boston, MA, September 21, 2015 /PRNewswire/ The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI), part of the University of Utah Health Care system in Salt Lake City, UT, has become the first site in North America to be designated as a Center of Excellence for Preclinical Imaging by Mediso Ltd. and its affiliate company Mediso USA.
Tübingen, Germany, 23 February, 2015: University of Tübingen and Mediso enters into a collaboration to develop a preclinical PET insert for simultaneous acquisition in high field MRI systems
GÖTEBORG, Sweden, October 20, 2014: Mediso Ltd announced today at the annual congress of the European Association of Nuclear Medicine the launch of new MRI subsystems with 3 and 7 Tesla field strength. This cryogen-free based technology is to be integrated into the nanoScan pre-clinical multimodality imaging platform.
WMIC 2016, New York, NY
September 7-10, 2016
ESMRMB 2016, Vienna, Austria
September 29 - October 1, 2016
EANM 2016, Barcelona, Spain
October 15-19, 2016
IEEE MIC 2016, Strasbourg, France
November 1-3, 2016
Copyright © 2013 Mediso USA All rights reserved.